Cancer That Kills the Young May Have Met Its Match
He agrees with Yanik that the next important step is follow-up
of the patients to determine long-term prognosis.
To that end, Yanik and his University of Michigan team has
embarked on a new trial with the University of California, San Francisco,
Children's Hospital of Los Angeles, and the Children's Hospital of Philadelphia
to use a common MIBG protocol and the stem cell purging process.